| ¿µ¹® | heparin | ÇÑ±Û | ÇìÆÄ¸° |
|---|---|---|---|
| ¼³¸í | Ç÷¾× ÀÀ°í¸¦ ¸·´Â ÀÛ¿ëÀ» ÇÏ´Â ´Ù´ç·ùÀÇ È²»ê¿¡½ºÅ׸£. °íµîµ¿¹°ÀÇ °¢Á¾ Á¶Á÷¿¡ ³Î¸® ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, ¼ö¼ú ÈÄÀÇ Ç÷ÀüÁõÀ» ¸·´Â µ¥ ¾´´Ù. Ç÷¾×ÀÀ°í¶õ ÁöÇ÷ÀÇ ÇÑ °úÁ¤À¸·Î ¼¶À¯¼Ò¶õ ¹°ÁúÀ» ¸¸µé¾î ³»´Â °úÁ¤ÀÌ´Ù. ÀÌ ¼¶À¯¼Ò´Â ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¿¡ ÀÛ¿ëÇÏ¿© ¿©·¯ °¡Áö ¼¼Æ÷µéÀ» ¾ô¾î ¹´Â ¿ªÇÒÀ» ÇÏ¿© °á±¹ ¼Õ»óµÈ Ç÷°ü¿¡¼ Ç÷¾×ÀÇ ¼Ò½ÇÀ» ¸·´Â´Ù. ÀÌ ¼¶À¯¼Ò´Â Æ®·Òºó¿¡ ÀÇÇØ ¼¶À¯¼Ò¿ø¿¡¼ ÀüȯµÈ´Ù. ÇìÆÄ¸°À̶ó´Â ¹°ÁúÀº ÀÌ Æ®·ÒºóÀ» ¾ïÁ¦ÇÏ´Â Çׯ®·ÒºóÀ» Ȱ¼ºÈÇÏ´Â ¹°ÁúÀÌ´Ù. |
||
| ASAL | arginosuccinic acid lyase |
|---|---|
| ASL | antistreptolysin; argininosuccinate lyase |
| ICL | idiopathic CD4 T-cell lymphocytopenia; iris-clip lens; isocitrate lyase |
| TPL | third party liability; titanium proximal loading; tumor progression locus; tyrosine phenol-lyase |
| BH | base hospital; benzalkonium and heparin; bill of health; birth history; Bishop-Harman [instruments];... |
| LMW heparin | Low Molecular Weight heparin |
|---|---|
| ACL | ATP citrate lyase |
| ASL | Argininosuccinate lyase |
| HPL | Hydroperoxide lyase |
| ICL | Isocitrate lyase |
| heparin lyase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
|---|
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
|---|---|
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| heparin unit | The quantity of heparin required to keep 1 ml of cat's blood fluid for 24 hr at 0°C; it is equivalent approximately to 0.002 mg of pure heparin. Synonym: Howell unit. (05 Mar 2000) |
| adenylosuccinate lyase | <enzyme> An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyses the conversion of 5'-phosphoribosyl-4-(n-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. Chemical name: N(6)-(1,2-Dicarboxyethyl)AMP AMP-lyase Registry number: EC 4.3.2.2 (12 Dec 1998) |
| adenylylosuccinate lyase | <enzyme> An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyses the conversion of 5'-phosphoribosyl-4-(n-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. Chemical name: N(6)-(1,2-Dicarboxyethyl)AMP AMP-lyase Registry number: EC 4.3.2.2 (12 Dec 1998) |
| alkylmercury lyase | <enzyme> From bacteria; catalyses the protonolysis of the carbon-mercury bond to give hydrocarbon and mercury as a mercaptide Registry number: EC 4.99.1.2 Synonym: organomercury lyase, organomercurial lyase, phenylmercury lyase (26 Jun 1999) |
| alpha-1,4-glucan lyase | <enzyme> Degrades alpha-1,4-glucan to produce 1,5-anhydrofructose; from seaweeds gracilariopsis lemaneiformis and gracilaria verrucosa; mw 111 kD; amino acid sequence has been determined Registry number: EC 4.2.2.- Synonym: alpha-1,4-glucan 4-lyase (26 Jun 1999) |
| alpha-pinene oxide lyase | <enzyme> From nocardia sp. Strain p18.3; catalyses the cleavage of both rings of the bicyclic structure with the formation of 2-methyl-5-isopropylhexa-2,5-dienal Registry number: EC 4.1.2.- Synonym: alpha-pinene oxide lyase (decyclizing) (26 Jun 1999) |
| aminodeoxychorismate lyase | <enzyme> Catalyses the conversion of aminodeoxychorismate to paba and pyruvate Registry number: EC 4.1.3.- Synonym: enzyme x, folate biosynthesis, 4-amino-4-deoxychorismate pyruvate-lyase (26 Jun 1999) |
Synonyms : Neutralase, Eliminase, Heparin, I, Heparinase, Lyase, Heparin
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|